Literature DB >> 1588356

Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis.

J C Hornberger1, D A Redelmeier, J Petersen.   

Abstract

Cost-effectiveness analysis is emerging as an approach for determining the relative value of health care programs, technologic innovations, and clinical decisions. Increasingly, patients' stated values for quality of life are applied as adjustment in these analyses; the results may vary depending on how individuals assess their well-being. We interviewed 58 patients with chronic renal failure to determine the level of agreement among six methods for assessing well-being, and to determine the effects of variation in assessed well-being on the results of a cost-effectiveness analysis of in-center hemodialysis. Patients reported well-being using the Sickness Impact Profile, Campbell Index of Well-being, Kaplan-Bush Index of Well-being, categorical scaling, standard gamble, and time trade-off. We found that patient well-being was substantially higher as evaluated by the Sickness Impact Profile compared to the other five methods. The Sickness Impact Profile and the Kaplan-Bush Index of Well-being provided much narrower distributions of assessed values relative to other measures. Correlations among assessment methods were poor (Spearman rank-correlation coefficients range: 0.094-0.519). Discrepancies among indices were particularly vivid when we evaluated data at the individual level; many patients reported a high level of well-being according to one index and a low level of well-being according to a different index. The cost effectiveness of in-center hemodialysis varied from $34,893 to $45,254 per quality-adjusted life-year saved according to the Sickness Impact Profile and standard-gamble technique respectively. The substantial variability in patients' stated quality of life may preclude the use of a single method to analyze the cost effectiveness of a health program.

Entities:  

Mesh:

Year:  1992        PMID: 1588356     DOI: 10.1016/0895-4356(92)90099-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  29 in total

1.  Clustering and the design of preference-assessment surveys in healthcare.

Authors:  A Lin; L A Lenert; M A Hlatky; K M McDonald; R A Olshen; J Hornberger
Journal:  Health Serv Res       Date:  1999-12       Impact factor: 3.402

Review 2.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

3.  Improving the sensitivity of the time trade-off method: results of an experiment using chained TTO questions.

Authors:  G C Morrison; A Neilson; M Malek
Journal:  Health Care Manag Sci       Date:  2002-02

4.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

5.  Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.

Authors:  P Carmichael; J Popoola; I John; P E Stevens; A R Carmichael
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

Review 6.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

7.  A meta-analysis of quality-of-life estimates for stroke.

Authors:  Tammy O Tengs; Ting H Lin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Economic evaluation in healthcare. A brief history and future directions.

Authors:  K Blumenschein; M Johannesson
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

9.  Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?

Authors:  S B Stewart; C D Scales; J W Moul; S D Reed
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-07-10       Impact factor: 5.554

10.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.